Community Pharmacy England (CPE) - News updates

Drug alert number: EL (24)A/50 Date issued: 23 October 2024 Bristol Laboratories Ltd. are recalling one batch of Phenobarbital Bristol Labs 15mg Tablets as a precautionary measure due to the potential of contamination of small metallic particles within the tablets. PL 17907/0175 DMRC Number: DMRC-32910584 SNOMED Code:21039211000001106 Batch No Expiry Date Pack Size First Distributed [...] The post MHRA Class 2 Medicines Recall: Phenobarbital Bristol Labs 15mg Tablets (Bristol Laboratories Ltd) appeared first on Community Pharmacy England.

The Secretary of State for Health and Social Care has this week launched a national conversation on the NHS, seeking input and ideas to shape the future of a reformed health service. Patients, members of the public and anyone working in the NHS have been invited to submit their views and ideas via the change.nhs.uk portal. [...] The post Secretary of State launches national conversation on health service appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (22/10/2024) announced the following list of price concessions for October 2024: Drug Pack size Price concession Agomelatine 25mg tablets 28 £13.50 Amitriptyline 50mg/5ml oral solution sugar free 150 [...] The post October 2024 Price Concessions – 2nd Update appeared first on Community Pharmacy England.

National Patient Safety Alert: Discontinuation of Kay-Cee-L® (potassium chloride 375mg/5ml) (potassium chloride 5mmol/5ml) syrup National Patient Safety Alert Reference Number: NatPSA/2024/011/DHSC Date issued: 21-Oct-2024 This NatPSA supersedes NatPSA/2024/008/DHSC This alert is for action by: All organisations involved in prescribing, dispensing and administering Kay-Cee-L® (potassium chloride 375mg/5ml) (potassium chloride 5mmol/5ml) syrup. This is a safety critical [...] The post National Patient Safety Alert: Discontinuation of Kay-Cee-L® (potassium chloride 375mg/5ml) (potassium chloride 5mmol/5ml) syrup appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Information: Paracetamol 500mg Effervescent Tablets (Kent Pharma UK) Drug alert number: EL(24)A/49 Date issued: 21 October 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Paracetamol 500mg Effervescent Tablets (Kent Pharma UK) Company name: Kent Pharma UK Product name: Paracetamol [...] The post MHRA Class 4 Medicines Defect Information: Paracetamol 500mg Effervescent Tablets (Kent Pharma UK) appeared first on Community Pharmacy England.

Community pharmacy owners are being asked to share their views and concerns as we head into winter, as well as any further feedback they have, before the next full Community Pharmacy England Committee meeting in November. This winter will be a critical time for the sector as community pharmacy owners desperately need answers about their [...] The post Share your opinions on Winter Pressures: Pharmacy Owner Views Sought appeared first on Community Pharmacy England.

Staffing pressures are significantly impacting community pharmacies, adding huge workload pressures for all those who work in them and hampering their ability to help patients and the public, a report from Community Pharmacy England has found. Pharmacy owners and team members across England paint a vivid picture of the severe consequences caused by staffing shortages, [...] The post Critical staffing pressures in Community Pharmacies hitting patients appeared first on Community Pharmacy England.

Community pharmacy has been referenced several times in the Houses of Parliament this week as MPs have quizzed Health Ministers on access to primary care services and pharmacy funding during two sessions. During Health Questions on Tuesday, Warinder Juss MP (Labour) enquired about the level of patient access to primary care services. In response the [...] The post Multiple pharmacy mentions in Parliament appeared first on Community Pharmacy England.

Update 18/10/2024 – The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocol (SSP) for Monomax® 60XL tablets (SSP074). SSP074 was due to expire on 18 October 2024 but the end date has been further extended to Friday 15 November 2024. There are no further changes to SSP075 [...] The post SSP074 – Monomax® 60XL tablets extended appeared first on Community Pharmacy England.

Community Pharmacy England CEO Janet Morrison gave an important sector update at this week’s Pharmacy Show, while other members of the team joined other key sessions and engaged with visitors to our exhibition stand. Thank you to all community pharmacy owners and others who took this opportunity to engage with us, sharing views and asking [...] The post Pharmacy Show hears our ambitions for future of community pharmacy appeared first on Community Pharmacy England.